Ian C Scott, Opeyemi Babatunde, Christopher Barker, Rebecca Beesley, Richard Beesley, Hollie Birkinshaw, Mel Brooke, Hema Chaplin, Lara Chapman, Coziana Ciurtin, James Dale, Dervil Dockrell, Emma Dures, Kathyrn Harrison, Meghna Jani, Charlotte Lee, Maura McCarron, Christian D Mallen, Assie O'Connor, Claire Pidgeon, Tamar Pincus, Dee Pratt, Yeliz Prior, Karim Raza, Zoe Rutter-Locher, Seema Sharma, Katie Shaw, Samantha Small, Tilli Smith, Lesley Tiffin, Jordan Tsigarides, Mikalena Xenophontos, Nicholas G Shenker
{"title":"Pain management in people with inflammatory arthritis: British Society for Rheumatology guideline scope.","authors":"Ian C Scott, Opeyemi Babatunde, Christopher Barker, Rebecca Beesley, Richard Beesley, Hollie Birkinshaw, Mel Brooke, Hema Chaplin, Lara Chapman, Coziana Ciurtin, James Dale, Dervil Dockrell, Emma Dures, Kathyrn Harrison, Meghna Jani, Charlotte Lee, Maura McCarron, Christian D Mallen, Assie O'Connor, Claire Pidgeon, Tamar Pincus, Dee Pratt, Yeliz Prior, Karim Raza, Zoe Rutter-Locher, Seema Sharma, Katie Shaw, Samantha Small, Tilli Smith, Lesley Tiffin, Jordan Tsigarides, Mikalena Xenophontos, Nicholas G Shenker","doi":"10.1093/rap/rkae128","DOIUrl":null,"url":null,"abstract":"<p><p>Pain is a common symptom in people with inflammatory arthritis (IA), which has far-reaching impacts on their lives. Recent electronic health record studies demonstrate that UK-based pain care in people with IA commonly involves the prescribing of long-term opioids and gabapentinoids, despite an absence of trial evidence for their efficacy. Patient surveys suggest that non-pharmacological pain management is underused. A UK-specific guideline on pain management for people with IA is required to resolve this. This scoping document outlines the context and prioritized clinical questions for the first British Society for Rheumatology (BSR) guideline on pain management for people with IA. The guideline aims to provide evidence-based recommendations on how pain can be best managed in people with IA (including its assessment, and pharmacological and non-pharmacological treatments), ensuring that people with IA in the UK are offered evidence-based pain management strategies. The guideline is for healthcare professionals involved in the care of people with IA of all ages and genders, people with IA and their families and carers, NHS managers and healthcare commissioners, and other relevant stakeholders such as patient organizations. It will be developed using the methods outlined in the BSR's 'Creating Clinical Guidelines' protocol.</p>","PeriodicalId":21350,"journal":{"name":"Rheumatology Advances in Practice","volume":"8 4","pages":"rkae128"},"PeriodicalIF":2.1000,"publicationDate":"2024-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11573413/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rheumatology Advances in Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/rap/rkae128","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Pain is a common symptom in people with inflammatory arthritis (IA), which has far-reaching impacts on their lives. Recent electronic health record studies demonstrate that UK-based pain care in people with IA commonly involves the prescribing of long-term opioids and gabapentinoids, despite an absence of trial evidence for their efficacy. Patient surveys suggest that non-pharmacological pain management is underused. A UK-specific guideline on pain management for people with IA is required to resolve this. This scoping document outlines the context and prioritized clinical questions for the first British Society for Rheumatology (BSR) guideline on pain management for people with IA. The guideline aims to provide evidence-based recommendations on how pain can be best managed in people with IA (including its assessment, and pharmacological and non-pharmacological treatments), ensuring that people with IA in the UK are offered evidence-based pain management strategies. The guideline is for healthcare professionals involved in the care of people with IA of all ages and genders, people with IA and their families and carers, NHS managers and healthcare commissioners, and other relevant stakeholders such as patient organizations. It will be developed using the methods outlined in the BSR's 'Creating Clinical Guidelines' protocol.
疼痛是炎症性关节炎(IA)患者的常见症状,对他们的生活影响深远。最近的电子健康记录研究表明,英国对炎症性关节炎患者的疼痛治疗通常包括开具长期阿片类药物和加巴喷丁类药物的处方,尽管缺乏对其疗效的试验证据。患者调查显示,非药物止痛疗法使用不足。为解决这一问题,需要制定一份针对英国的 IA 患者疼痛管理指南。本范围界定文件概述了第一份英国风湿病学会(BSR)IA 患者疼痛治疗指南的背景和优先临床问题。该指南旨在就如何对 IA 患者的疼痛进行最佳管理(包括疼痛评估、药物和非药物治疗)提供循证建议,确保为英国的 IA 患者提供循证疼痛管理策略。该指南的对象包括:参与治疗不同年龄和性别 IA 患者的医护专业人员、IA 患者及其家人和照顾者、NHS 管理人员和医护专员,以及患者组织等其他相关利益方。该指南将采用 BSR 的 "创建临床指南 "协议中概述的方法制定。